{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:12:25Z","timestamp":1791357145858,"version":"4.3.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1093\/ije\/dyg155","type":"journal-article","created":{"date-parts":[[2003,12,17]],"date-time":"2003-12-17T15:12:41Z","timestamp":1071673961000},"page":"961-966","source":"Crossref","is-referenced-by-count":48,"title":["Antidepressant medication use and breast cancer risk: a case-control study"],"prefix":"10.1093","volume":"32","author":[{"given":"Allan","family":"Steingart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Cotterchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Kreiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2003,12]]},"reference":[{"key":"key\n\t\t\t\t20170408082403_R1","doi-asserted-by":"crossref","unstructured":"Cotterchio M, Kreiger N, Darlington G, Steingart A. Antidepressant medication use and breast cancer risk. Am J Epidemiol2000; 151:951\u201357.","DOI":"10.1093\/oxfordjournals.aje.a010138"},{"key":"key\n\t\t\t\t20170408082403_R2","doi-asserted-by":"crossref","unstructured":"Halbreich U, Shen J, Panaro V. Are chronic psychiatric patients at increased risk for developing breast cancer? [see comments]. Am J Psychiatry1996;153:559\u201360.","DOI":"10.1176\/ajp.153.4.559"},{"key":"key\n\t\t\t\t20170408082403_R3","doi-asserted-by":"crossref","unstructured":"Kelly JP, Rosenberg L, Palmer JR et al. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. Am J Epidemiol1999;150:861\u201368.","DOI":"10.1093\/oxfordjournals.aje.a010091"},{"key":"key\n\t\t\t\t20170408082403_R4","doi-asserted-by":"crossref","unstructured":"Wallace RB, Sherman BM, Bean JA. A case-control study of breast cancer and psychotropic drug use. Oncol1982;39:279\u201383.","DOI":"10.1159\/000225651"},{"key":"key\n\t\t\t\t20170408082403_R5","doi-asserted-by":"crossref","unstructured":"Sharpe CR, Collet JP, Belzile E, Hanley JA, Boivin JF. The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer2002;86:92\u201397.","DOI":"10.1038\/sj.bjc.6600013"},{"key":"key\n\t\t\t\t20170408082403_R6","doi-asserted-by":"crossref","unstructured":"Wang PS, Walker AM, Tsuang MT, Orav EJ, Levin R, Avorn J. Antidepressant use and the risk of breast cancer: a non-association. J Clin Epidemiol2001;54:728\u201334.","DOI":"10.1016\/S0895-4356(00)00354-1"},{"key":"key\n\t\t\t\t20170408082403_R7","unstructured":"Friedman GD, Ury HK. Screening for possible drug carcinogenicity: second report of findings. J Natl Cancer Inst1983;71:1165\u201375."},{"key":"key\n\t\t\t\t20170408082403_R8","unstructured":"Selby JV, Friedman GD, Fireman BH. Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res1989;49:5736\u201347."},{"key":"key\n\t\t\t\t20170408082403_R9","unstructured":"Hilakivi-Clarke LWA, Lippman ME. Neonatal antidepressant treatment promotes DMBA-induced mammary tumor growth. Proc Am Assoc Cancer Res1993;34:184."},{"key":"key\n\t\t\t\t20170408082403_R10","unstructured":"Brandes LJ, Arron RJ, Bogdanovic RP et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res1992;52:3796\u2013800."},{"key":"key\n\t\t\t\t20170408082403_R11","doi-asserted-by":"crossref","unstructured":"Iishi H, Tatsuta M, Baba M, Taniguchi H. Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis1993;14:1837\u201340.","DOI":"10.1093\/carcin\/14.9.1837"},{"key":"key\n\t\t\t\t20170408082403_R12","unstructured":"Bendele RA, Adams ER, Hoffman WP, Gries CL, Morton DM. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res1992;52:6931\u201335."},{"key":"key\n\t\t\t\t20170408082403_R13","unstructured":"Tucker WE. Preclinical toxicology of bupropion: an overview. J Clin Psychiatry1983;44:60\u201362."},{"key":"key\n\t\t\t\t20170408082403_R14","doi-asserted-by":"crossref","unstructured":"Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol1995;48:1407\u201312.","DOI":"10.1016\/0895-4356(95)00545-5"},{"key":"key\n\t\t\t\t20170408082403_R15","doi-asserted-by":"crossref","unstructured":"Hume AL, Barbour MM, Lapane KL, Carleton RA. Is antidepressant use changing? Prevalence and clinical correlates in two New England communities. Pharmacotherapy1995;15:78\u201384.","DOI":"10.1002\/j.1875-9114.1995.tb04334.x"},{"key":"key\n\t\t\t\t20170408082403_R16","doi-asserted-by":"crossref","unstructured":"Rosholm JU, Gram LF, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol1997;52:205\u201309.","DOI":"10.1007\/s002280050275"},{"key":"key\n\t\t\t\t20170408082403_R17","doi-asserted-by":"crossref","unstructured":"Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol1998;51:273\u201383.","DOI":"10.1016\/S0895-4356(97)00238-2"},{"key":"key\n\t\t\t\t20170408082403_R18","doi-asserted-by":"crossref","unstructured":"Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst1993; 85:892\u201397.","DOI":"10.1093\/jnci\/85.11.892"},{"key":"key\n\t\t\t\t20170408082403_R19","doi-asserted-by":"crossref","unstructured":"Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst1995;87:1681\u201385.","DOI":"10.1093\/jnci\/87.22.1681"},{"key":"key\n\t\t\t\t20170408082403_R20","doi-asserted-by":"crossref","unstructured":"Gilbart E, Kreiger N. Improvement in cumulative response rates following implementation of a financial incentive. Am J Epidemiol1998;148:97\u201399.","DOI":"10.1093\/oxfordjournals.aje.a009565"},{"key":"key\n\t\t\t\t20170408082403_R21","unstructured":"CYTEL Software Corporation. Egret for Windows. Cambridge, MA: 1999."},{"key":"key\n\t\t\t\t20170408082403_R22","doi-asserted-by":"crossref","unstructured":"Colditz GA, Atwood KA, Emmons K et al. Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index. Cancer Causes Control2000;11:477\u201388.","DOI":"10.1023\/A:1008984432272"},{"key":"key\n\t\t\t\t20170408082403_R23","doi-asserted-by":"crossref","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol1993;138:923\u201336.","DOI":"10.1093\/oxfordjournals.aje.a116813"},{"key":"key\n\t\t\t\t20170408082403_R24","unstructured":"Cotterchio M, Kreiger N, Sloan M, Steingart A. Non-steroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomark Prev2001;10:1213\u201317."},{"key":"key\n\t\t\t\t20170408082403_R25","doi-asserted-by":"crossref","unstructured":"Cotterchio M, Kreiger N, Darlington G, Steingart A. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol1999;9:283\u201389.","DOI":"10.1016\/S1047-2797(98)00072-6"},{"key":"key\n\t\t\t\t20170408082403_R26","doi-asserted-by":"crossref","unstructured":"Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study. J Behav Med1988;11:1\u201313.","DOI":"10.1007\/BF00846165"},{"key":"key\n\t\t\t\t20170408082403_R27","doi-asserted-by":"crossref","unstructured":"Knekt P, Raitasalo R, Heliovaara M et al. Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol1996;144:1096\u2013103.","DOI":"10.1093\/oxfordjournals.aje.a008887"},{"key":"key\n\t\t\t\t20170408082403_R28","doi-asserted-by":"crossref","unstructured":"Hahn RC, Petitti DB. Minnesota Multiphasic Personality Inventory-rated depression and the incidence of breast cancer. Cancer1988; 61:845\u201348.","DOI":"10.1002\/1097-0142(19880215)61:4<845::AID-CNCR2820610434>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20170408082403_R29","doi-asserted-by":"crossref","unstructured":"Butow PN, Hiller JE, Price MA, Thackway SV, Kricker A, Tennant CC. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res2000;49:169\u201381.","DOI":"10.1016\/S0022-3999(00)00156-2"},{"key":"key\n\t\t\t\t20170408082403_R30","doi-asserted-by":"crossref","unstructured":"Price MA, Tennant CC, Butow PN et al. The role of psychosocial factors in the development of breast carcinoma: Part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer2001;91:686\u201397.","DOI":"10.1002\/1097-0142(20010215)91:4<686::AID-CNCR1052>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20170408082403_R31","doi-asserted-by":"crossref","unstructured":"Price MA, Tennant CC, Smith RC et al. The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality. Cancer2001;91:679\u201385.","DOI":"10.1002\/1097-0142(20010215)91:4<679::AID-CNCR1051>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20170408082403_R32","unstructured":"Friedman GD. Psychiatrically-diagnosed depression and subsequent cancer. Cancer Epidemiol Biomarkers Prev1994;3:11\u201313."},{"key":"key\n\t\t\t\t20170408082403_R33","doi-asserted-by":"crossref","unstructured":"Nicholas L, Dawkins K, Golden RN. Psychoneuroendocrinology of depression. Prolactin. Psychiatr Clin North Am1998;21:341\u201358.","DOI":"10.1016\/S0193-953X(05)70009-5"},{"key":"key\n\t\t\t\t20170408082403_R34","doi-asserted-by":"crossref","unstructured":"Arya DK. Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry1994;165:728\u201333.","DOI":"10.1192\/bjp.165.6.728"},{"key":"key\n\t\t\t\t20170408082403_R35","doi-asserted-by":"crossref","unstructured":"Shou M, Korzekwa KR, Brooks EN, Krausz KW, Gonzalez FJ, Gelboin HV. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Carcinogenesis1997;18:207\u201314.","DOI":"10.1093\/carcin\/18.1.207"},{"key":"key\n\t\t\t\t20170408082403_R36","doi-asserted-by":"crossref","unstructured":"Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol1991;4:391\u2013407.","DOI":"10.1021\/tx00022a001"},{"key":"key\n\t\t\t\t20170408082403_R37","doi-asserted-by":"crossref","unstructured":"Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brosen K. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol1996;51:73\u201378.","DOI":"10.1007\/s002280050163"},{"key":"key\n\t\t\t\t20170408082403_R38","doi-asserted-by":"crossref","unstructured":"Nordenberg J, Fenig E, Landau M, Weizman R, Weizman A. Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol1999;58:1229\u201336.","DOI":"10.1016\/S0006-2952(99)00156-2"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/32\/6\/961\/11434819\/320961_dyg155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T17:59:13Z","timestamp":1704995953000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/dyg155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2003,12]]},"published-print":{"date-parts":[[2003,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyg155","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}